Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2026-02-25 @ 7:02 PM
Study NCT ID:
NCT05087602
Status:
UNKNOWN
Last Update Posted:
2021-10-21
First Post:
2021-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Toripalimab Combined With Anlotinib in Unresectable Locally Advanced or Metastatic Acral Malignant Melanoma
Sponsor:
Qilu Hospital of Shandong University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10-30
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-08
First Submit QC Date:
None
Study First Post Date:
2021-10-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-08
Last Update Post Date:
2021-10-21
Last Update Post Date Type:
ACTUAL